When it comes to
Regenerative Medicine, we talk about stem cells,
allogenic and autogenic cells, umbilical cord blood banking, tissue engineering
and CAR T therapies.
Beyond a set
of realities related to the success vs. failure
ratios in developing regenerative medicine drugs and therapies, the technology
is gaining momentum in the USA, Japan, South Korea, China and Europe.
According to
Research and Markets, the global regenerative
medicine market was worth $18.9 billion in 2016 and will grow to over $53.7
billion by 2021, with a CAGR of 23.3% between this time frame.
Comments
Post a Comment